Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
- PMID: 6967514
- PMCID: PMC2185954
- DOI: 10.1084/jem.152.2.361
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
Abstract
A method is presented for covalently bonding Haemophilus influenzae type b capsular polysaccharide (HIB Ps) to several proteins. The method is efficient and relies upon the use of adipic dihydrazide as a spacer between the capsular polysaccharide and the carrier protein. In contrast to the poor immunogenicity of the purified HIB Ps in mice and rabbits, the HIB Ps-protein conjugates induced serum anti-type b antibodies having bactericidal activity at levels shown to be protective in humans when low doses were injected subcutaneously in a saline solution. The antibody response in mice was related to the dose of the conjugates, increased with the number of injections, and could be primed by the previous injection of the carrier protein. The HIB Ps-protein conjugates were immunogenic in three different mouse strains. The importance of the carrier molecule for the enhanced immunogenicity of the HIB Ps-protein conjugates was shown by the failure of HIB Ps hybrids prepared with either the homologous polysaccharide or pneumococcus type 3 polysaccharide to induce antibodie in mice. Rabbits injected with the HIB Ps-protein conjugates emulsified in Freund's adjuvant produced high levels of serum anti-type b antibodies which induced a bactericidal effect upon H. influenzae type b organisms. It is proposed that the HIB Ps component of the polysaccharide protein conjugates has been converted to a thymic-dependent immunogen. This method may be used to prepare protein-polysaccharide conjugates with HIB Ps and other polysaccharides to be considered for human use.
Similar articles
-
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.Infect Immun. 1983 Apr;40(1):245-56. doi: 10.1128/iai.40.1.245-256.1983. Infect Immun. 1983. PMID: 6601061 Free PMC article.
-
Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.Infect Immun. 1984 Sep;45(3):582-91. doi: 10.1128/iai.45.3.582-591.1984. Infect Immun. 1984. PMID: 6332076 Free PMC article.
-
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.Infect Immun. 1986 May;52(2):519-28. doi: 10.1128/iai.52.2.519-528.1986. Infect Immun. 1986. PMID: 3516876 Free PMC article.
-
Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines.Biologicals. 1994 Dec;22(4):397-402. doi: 10.1006/biol.1994.1062. Biologicals. 1994. PMID: 7779368 Review.
-
Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.Vaccine. 1993;11 Suppl 1:S46-51. doi: 10.1016/0264-410x(93)90160-y. Vaccine. 1993. PMID: 8447176 Review.
Cited by
-
An Exopolysaccharide from the Cyanobacterium Arthrospira platensis May Utilize CH-π Bonding: A Review of the Isolation, Purification, and Chemical Structure of Calcium-Spirulan.ACS Omega. 2024 Aug 10;9(33):35243-35255. doi: 10.1021/acsomega.4c05066. eCollection 2024 Aug 20. ACS Omega. 2024. PMID: 39184464 Free PMC article. Review.
-
A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars.Front Immunol. 2024 Jan 9;14:1304170. doi: 10.3389/fimmu.2023.1304170. eCollection 2023. Front Immunol. 2024. PMID: 38264668 Free PMC article.
-
Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines.Vaccines (Basel). 2023 Nov 28;11(12):1770. doi: 10.3390/vaccines11121770. Vaccines (Basel). 2023. PMID: 38140177 Free PMC article.
-
Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals.Front Mol Biosci. 2023 Nov 16;10:1284515. doi: 10.3389/fmolb.2023.1284515. eCollection 2023. Front Mol Biosci. 2023. PMID: 38046812 Free PMC article.
-
[The new 15-valent pneumococcal conjugate vaccine for the prevention of S. pneumoniae infections in pediatric age: a Health Technology Assessment].J Prev Med Hyg. 2023 Jun 29;64(1 Suppl 1):E1-E160. doi: 10.15167/2421-4248/jpmh2023.64.1s1. eCollection 2023 Mar. J Prev Med Hyg. 2023. PMID: 37655211 Free PMC article. Italian. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources